Guizhou Bailing Group Pharmaceutical Co Ltd (002424) — Strategic Asset Allocation Index
Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a Strategic Asset Allocation Index of 26.7% as of September 2023. Strategic assets (PP&E of CN¥1.08 Billion plus long-term investments of CN¥-) total CN¥1.08 Billion, measured against net assets of CN¥4.05 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Guizhou Bailing Group Pharmaceutical Co (002424) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Guizhou Bailing Group Pharmaceutical Co Ltd Strategic Asset Allocation Index (2010–2022)
This chart shows how Guizhou Bailing Group Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 13 annual periods from 2010 to 2022. As of September 2023, the index stands at 26.7%, representing strategic assets of CN¥1.08 Billion against net assets of CN¥4.05 Billion CNY. See 002424 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Guizhou Bailing Group Pharmaceutical Co Ltd (2010–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Guizhou Bailing Group Pharmaceutical Co Ltd from 2010 to 2022, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 002424 stock market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 26.6% | CN¥1.06 Billion | CN¥1.06 Billion | CN¥- | CN¥4.00 Billion | ▲ +2.3 pp |
| 2021 | 24.3% | CN¥963.73 Million | CN¥963.73 Million | CN¥- | CN¥3.96 Billion | ▲ +6.9 pp |
| 2020 | 17.4% | CN¥682.74 Million | CN¥682.74 Million | CN¥- | CN¥3.92 Billion | ▼ -0.3 pp |
| 2019 | 17.8% | CN¥734.47 Million | CN¥734.47 Million | CN¥- | CN¥4.14 Billion | ▼ -22.6 pp |
| 2018 | 40.4% | CN¥1.59 Billion | CN¥748.84 Million | CN¥836.34 Million | CN¥3.92 Billion | ▲ +17.1 pp |
| 2017 | 23.3% | CN¥807.66 Million | CN¥718.81 Million | CN¥88.84 Million | CN¥3.47 Billion | ▲ +1.0 pp |
| 2016 | 22.3% | CN¥684.63 Million | CN¥675.79 Million | CN¥8.84 Million | CN¥3.07 Billion | ▼ -1.6 pp |
| 2015 | 24.0% | CN¥642.27 Million | CN¥633.43 Million | CN¥8.84 Million | CN¥2.68 Billion | ▼ -4.8 pp |
| 2014 | 28.8% | CN¥675.39 Million | CN¥675.39 Million | CN¥- | CN¥2.35 Billion | ▼ -3.3 pp |
| 2013 | 32.0% | CN¥681.49 Million | CN¥681.49 Million | CN¥- | CN¥2.13 Billion | ▲ +2.5 pp |
| 2012 | 29.5% | CN¥602.45 Million | CN¥602.45 Million | CN¥- | CN¥2.04 Billion | ▲ +8.2 pp |
| 2011 | 21.3% | CN¥412.37 Million | CN¥412.37 Million | CN¥- | CN¥1.94 Billion | ▲ +11.3 pp |
| 2010 | 10.0% | CN¥184.51 Million | CN¥184.51 Million | CN¥- | CN¥1.85 Billion | — |